1. Home
  2. RIGL vs LVRO Comparison

RIGL vs LVRO Comparison

Compare RIGL & LVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIGL
  • LVRO
  • Stock Information
  • Founded
  • RIGL 1996
  • LVRO 2017
  • Country
  • RIGL United States
  • LVRO Brazil
  • Employees
  • RIGL N/A
  • LVRO N/A
  • Industry
  • RIGL Biotechnology: Pharmaceutical Preparations
  • LVRO Blank Checks
  • Sector
  • RIGL Health Care
  • LVRO Finance
  • Exchange
  • RIGL Nasdaq
  • LVRO Nasdaq
  • Market Cap
  • RIGL 335.5M
  • LVRO 279.6M
  • IPO Year
  • RIGL 2000
  • LVRO N/A
  • Fundamental
  • Price
  • RIGL $41.50
  • LVRO $1.73
  • Analyst Decision
  • RIGL Buy
  • LVRO Sell
  • Analyst Count
  • RIGL 5
  • LVRO 3
  • Target Price
  • RIGL $38.20
  • LVRO $1.88
  • AVG Volume (30 Days)
  • RIGL 845.0K
  • LVRO 14.7K
  • Earning Date
  • RIGL 08-05-2025
  • LVRO 09-05-2025
  • Dividend Yield
  • RIGL N/A
  • LVRO N/A
  • EPS Growth
  • RIGL N/A
  • LVRO N/A
  • EPS
  • RIGL 5.43
  • LVRO N/A
  • Revenue
  • RIGL $267,921,000.00
  • LVRO $1,667,345,189.00
  • Revenue This Year
  • RIGL $14.41
  • LVRO N/A
  • Revenue Next Year
  • RIGL $15.97
  • LVRO $11.45
  • P/E Ratio
  • RIGL $7.64
  • LVRO N/A
  • Revenue Growth
  • RIGL 105.62
  • LVRO N/A
  • 52 Week Low
  • RIGL $12.00
  • LVRO $1.58
  • 52 Week High
  • RIGL $43.72
  • LVRO $5.60
  • Technical
  • Relative Strength Index (RSI)
  • RIGL 86.20
  • LVRO 35.44
  • Support Level
  • RIGL $38.43
  • LVRO $1.58
  • Resistance Level
  • RIGL $41.25
  • LVRO $2.23
  • Average True Range (ATR)
  • RIGL 2.50
  • LVRO 0.14
  • MACD
  • RIGL 0.89
  • LVRO -0.03
  • Stochastic Oscillator
  • RIGL 89.85
  • LVRO 21.83

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

About LVRO Lavoro Limited

Lavoro Ltd operates in the agricultural inputs retail market, with operations spread across Brazil and Colombia, and an emergent agricultural input trading company in Uruguay. The reportable segments of the company include the Brazil Ag Retail, which comprises companies dedicated to the distribution of agricultural inputs such as crop protection, seeds, fertilizers and specialty products, in Brazil; Latam Ag Retail, which includes companies dedicated to the distribution of agricultural inputs outside Brazil (predominantly in Colombia); and the Crop Care. A substantial part of the company's overall revenue is generated from its Brazil Ag Retail segment.

Share on Social Networks: